Nanosecond, low voltage electro-endocrine-therapy for breast cancer treatment

Electroporation is the technique of applying high intensity, short duration pulses for effective drug/gene delivery for cancer therapies when conventional treatments do not work and/or costly with serious side effects and for chemo-resistive patients. Typically micro and millisecond pulses have been used by several researchers. Use of nanosecond pulse is gaining momentum due to its various advantages including cytoplasmic delivery of molecules. For this purpose, several kV/cm (10–30kV/cm), 10–300ns pulses have been used by previous researchers. Considering that it is always good to use as low a voltage as possible for patient treatments, we studied the efficacy of 20ns pulses at low electric field intensities of 200V/cm, 500V/cm, and 1200V/cm on MCF-7 breast cancer cells using Tamoxifen, the hormone drug for estrogen receptor positive cancer tumors. These pulses were applied for durations of a few minutes and their viabilities were studied at various Tamoxifen doses. Results indicate that higher doses and longer duration pulses are also effective in killing the cancer cells, indicating that nanosecond, low voltage electro-endocrine-therapy is a viable treatment for breast cancer patients.

[1]  Richard Nuccitelli,et al.  Optimized nanosecond pulsed electric field therapy can cause murine malignant melanomas to self‐destruct with a single treatment , 2010, International journal of cancer.

[2]  M. Tangney,et al.  Electrochemotherapy: Aspects of Preclinical Development and Early Clinical Experience , 2007, Annals of surgery.

[3]  U. Pliquett,et al.  Nanosecond pulsed electric fields cause melanomas to self-destruct , 2006, Conference Record of the 2006 Twenty-Seventh International Power Modulator Symposium.

[4]  Julie Gehl,et al.  Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. , 2003, Cancer treatment reviews.

[5]  K. Schoenbach,et al.  Nanosecond, high‐intensity pulsed electric fields induce apoptosis in human cells , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  K. Schoenbach,et al.  Intracellular effect of ultrashort electrical pulses , 2001, Bioelectromagnetics.

[7]  J. Gehl,et al.  Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy , 2000, Melanoma research.

[8]  G. A. Hofmann,et al.  Medical applications of electroporation , 2000 .

[9]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M J Jaroszeski,et al.  Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy , 1996, Cancer.

[11]  Antonella Vecchiato,et al.  Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients , 2008, Annals of Surgical Oncology.

[12]  M J Jaroszeski,et al.  Clinical trials for solid tumors using electrochemotherapy. , 2000, Methods in molecular medicine.